Atlas Trials

Oral Bioavailability and Mass Balance Trial With Pimasertib

Clinical trial NCT01713036 · COMPLETED

Trial details

NCT number
NCT01713036
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Locally Advanced or Metastatic Solid Tumors
Start date
2012-11-30
Primary completion
2014-07-31
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.